New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Biomarkers and Companion diagnostics: Payer Insights 09/26/2019
The Global Use of Medicine in 2019 and Outlook to 2023 01/29/2019
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019
The Growing Influence of the Institute of Clinical and… 11/21/2019
Medical Diagnostics: leveraging new opportunities from AI… 01/16/2020
The Future of Key Account Management in Pharma 09/26/2019